These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6642679)

  • 1. Lung tissue concentrations of cefoperazone.
    Wartenberg K; Tonak J; Knapp W
    Infection; 1983; 11(5):280-2. PubMed ID: 6642679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefoperazone pharmacokinetics in acute childhood meningitis.
    Chartrand SA; Marks MI; Johnston JT; Frederick DF; Scribner RK
    J Pediatr; 1983 Dec; 103(6):991-5. PubMed ID: 6644441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacokinetics of cefoperazone concentration in human lung tissue].
    Monden Y; Fujimoto Y; Nakahara K
    Jpn J Antibiot; 1986 Jan; 39(1):57-62. PubMed ID: 3702062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cefoperazone in ambulatory elderly volunteers compared with young adults.
    Meyers BR; Mendelson MH; Deeter RG; Srulevitch-Chin E; Sarni MT; Hirschman SZ
    Antimicrob Agents Chemother; 1987 Jun; 31(6):925-9. PubMed ID: 3619425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefoperazone pharmacokinetics and sputum levels after single/multiple i.m. injections in bronchopneumopathic patients and bone, pulmonary and prostatic tissue penetration.
    Braga PC; Scaglione F; Villa S; Scarpazza G; Gagliardi V; Biella G; Manganelli V; Paiola G; Fraschini F
    Int J Clin Pharmacol Res; 1983; 3(5):349-55. PubMed ID: 6678828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of cefoperazone into surgical wound drainage in patients undergoing head and neck surgery.
    Muder RR; Yu VL; Johnson J; Thearle P; Lyon J; Diven W
    Antimicrob Agents Chemother; 1984 Apr; 25(4):473-5. PubMed ID: 6732215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study on the levels of cefoperazone in urological organs].
    Fukatsu H; Waki M; Hatano Y; Hiraiwa S; Kikuchi T; Muramatsu T; Yamada Y; Nishikawa E; Satoh T; Honda N
    Hinyokika Kiyo; 1985 Jun; 31(6):1085-91. PubMed ID: 4061208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cefoperazone in healthy volunteers.
    Saudek F; Morávek J; Modr Z
    Czech Med; 1986; 9(3):162-5. PubMed ID: 3095076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefoperazone after single and multiple doses.
    Ripa S; La Rosa F; Dainelli B; Ecari U; Ruffilli MP
    Int J Clin Pharmacol Res; 1986; 6(2):171-5. PubMed ID: 3721648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biliary excretion and pharmacokinetics of cefoperazone in humans.
    Kemmerich B; Lode H; Borner K; Belmega D; Jendroschek T; Koeppe P; Goertz G
    J Antimicrob Chemother; 1983 Jul; 12(1):27-37. PubMed ID: 6619045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer of cefoperazone into human skin fluid.
    Sugiyama H; Hatano T; Takayanagi K; Aoyama H; Goto T
    Clin Ther; 1985; 7(5):607-10. PubMed ID: 4053148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of cefoperazone in the parturient.
    Gonik B; Feldman S; Pickering LK; Doughtie CG
    Antimicrob Agents Chemother; 1986 Dec; 30(6):874-6. PubMed ID: 3813513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Concentrations of cefoperazone in lung tissue].
    Alesina R; Ferrara A; Grassi FA; Panelli G; Volpato G
    G Ital Chemioter; 1986; 33(1):71-4. PubMed ID: 3817382
    [No Abstract]   [Full Text] [Related]  

  • 14. [A study of prostatic tissue levels of cefoperazone].
    Yoshida H; Hoshino M; Haraguchi C; Ogawa Y; Kawai N; Sakurai H; Ishihara Y; Higaki Y; Imamura K
    Hinyokika Kiyo; 1985 May; 31(5):871-4. PubMed ID: 2413746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition and excretion of cefoperazone in rabbits.
    Mariño EL; Fernández Lastra C; Gonzalez Alonso I; Dominguez-Gil A
    Arzneimittelforschung; 1987 Mar; 37(3):345-9. PubMed ID: 3593450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of cefoperazone in the field of obstetrics and gynecology. Susceptibility of clinical isolates to cefoperazone and cefoperazone concentrations in the exudate of the pelvic dead space].
    Cho N; Kimura T; Suzuki H; Fukunaga K; Kunii K; Komoriyama Y
    Jpn J Antibiot; 1984 Sep; 37(9):1607-19. PubMed ID: 6512980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study of prostatic tissue levels of latamoxef, cefoperazone and cefotaxime].
    Takeuchi N; Kinukawa T; Matsuura O; Hattori R; Hasegawa S; Ohshima S; Ono Y
    Hinyokika Kiyo; 1986 Dec; 32(12):1831-41. PubMed ID: 2435132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study of cefoperazone prostatic tissue levels: difference between the gland and capsule].
    Fukushima S; Miura T; Kondo I; Fujii H; Hirokawa M; Iwasaki A; Ishizuka E; Kitajima N
    Hinyokika Kiyo; 1983 Jan; 29(1):87-93. PubMed ID: 6203376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study on the interstitial passage of cefuroxime, cefoxitin, cefotaxime and cefoperazone in man by the suction skin blister method.
    Frongillo RF; Galuppo L; Moretti A
    Boll Ist Sieroter Milan; 1983 Nov; 62(5):412-6. PubMed ID: 6322818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study of prostatic tissue levels of ceftizoxime, cefoperazone and cefotaxime].
    Ikeda S; Ishibashi A; Koshiba K
    Hinyokika Kiyo; 1984 Aug; 30(8):1135-42. PubMed ID: 6083722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.